Formulation: 80 mM Tris, pH 8.0, with 0.3 mM DDC, 0.01% Tween 20, and 10% glycerol

Purity: ≥75% (estimated by SDS-PAGE)

• Cyclooxygenase 2
• Prostaglandin H Synthase 2

Formulation: 50 mM HEPES, pH 8.0, containing 300 mM sodium chloride, 1 mM DTT, and 10% glycerol

Purity: ≥90%

• PADI4
• PADI5
• Peptidylarginine Deiminase 4
• Protein Arginine Deiminase Type 4
• Protein Arginine Deiminase Type IV

Formulation: 80 mM Tris-HCl, pH 8.0, containing 0.3 mM DDC, 0.1% polysorbate 20, and 10% glycerol

• Cyclooxygenase 1
• PGHS-1
• Prostaglandin Endoperoxide Synthase 1
• Prostaglandin G/H Synthase 1
• Prostaglandin H2 Synthase 1

Formulation: 50 mM Tris, pH 8.0, with 150 mM NaCl and 5% glycerol

Purity: ≥85% estimated by SDS-PAGE

• Angiotensinogenase

Formulation: Each vial, when reconstituted to 500 μl with water, contains 50 μg of pertussis toxin in in 0.01 M sodium phosphate, 0.05 M sodium chloride, pH 7.0

Purity: ≥95% estimated by SDS-PAGE

Formulation: A solution in water (frozen)

Purity: ≥95% estimated by SDS-PAGE

• H3C1
• Histone H3.1

Formulation: TBS, pH 7.4, with 20% glycerol

Purity: ≥95% estimated by SDS-PAGE

• Cytosolic Epoxide Hydrolase (CEH)
• EPHX2
• Epoxide Hydrolase 2
• sEH

Formulation: 20 mM Hepes, pH 7.8, with 150 mM sodium chloride, 1 mM EDTA, 1 mM DTT, 0.5% CHAPS, and 20% glycerol

Purity: Cell Lysate: Resuspended 100,000 g pellet

• Anandamide Amidohydrolase 1
• FAAH
• Oleamide Hydrolase 1
• PSAB

Formulation: 40 mM Tris-HCl, pH 8.0, 110 mM sodium chloride, with 2.2 mM potassium chloride, 0.04% Tween 20, 3 mM DTT, and 20% glycerol

Purity: ≥65% estimated by SDS-PAGE

• Histone Deacetylase 6

Formulation: 10 mM Tris, pH 8.0

Purity: ≥55% estimated by SDS-PAGE

Formulation: 50 mM HEPES, pH 8.0, with 300 mM sodium chloride, and 10% glycerol

Purity: ≥90% estimated by SDS-PAGE

• C6orf150
• 2’3’-cGAMP Synthase
• cGAMP Synthase
• h-cGAS
• Cyclic GMP-AMP Synthase
• EC: 2.7.7.86
• Mab-21 domain containing protein 1
• MB21D1

Formulation: A solution in PBS, pH 7.4

Purity: ≥90% estimated by SDS-PAGE

• H3
• H3C1
• Histone H3.1

Formulation: 50 mM HEPES, pH 8.0, with 200 mM NaCl, 1 mM DTT and 10% glycerol

Purity: ≥80% estimated by SDS-PAGE

• PADI2
• PAD-H19
• Peptidylarginine Deiminase 2
• Protein Arginine Deiminase 2

Formulation: Lyophilized from a solution in PBS, pH 7.4, at 10 mg per vial. Reconstitution with 0.2 ml of water will yield 50 mg/ml solution in 1X PBS

• Advanced Glycation End Product - Bovine Serum Albumin
• Glucose AGE-BSA

Formulation: 100 mM Tris-HCl, pH 8.0, with 5 mM EGTA, 1mM calcium chloride, and 30% glycerol

Purity: Clarified lysate

• 5-LO
• 5-LOX
• ALOX5
• Arachidonate 5-lipoxygenase
• LOG5

Formulation: 50 mM HEPES, pH 7.4, with 10% glycerol, 8 µM BH₄, 0.08 mM DTT, 2% protease inhibitor cocktail (EDTA free), and 0.05% nuclease

Purity: 100,000 x g supernatant

• Hepatocyte NOS
• Inducible Nitric Oxide Synthase
• Inducible NO Synthase
• Inducible NOS
• Nitric Oxide Synthase 2
• NOS II
• hep-NOS

Formulation: 50 mM Tris-HCl, pH 8.0, with 150 mM sodium chloride and 5% glycerol

Purity: ≥90% estimated by SDS-PAGE

• Angiotensinogenase
• Angiotensin forming enzyme

Formulation: Frozen solution with 50 mM Tris-HCl, pH 7.4, 150 mM sodium chloride, and 10% glycerol

Purity: Homogeneous by SDS-PAGE. Clottable proteins: ≥90%

Formulation: 50 mM Tris pH 8.0, 150 mM sodium chloride, and 20% glycerol

Purity: ≥85% estimated by SDS-PAGE

• Fibronectin Type III Domain 5
• FNDC5
• FRCP2
• PeP

Formulation: A solid

Formulation: 50 mM sodium phosphate, pH 7.2, 100 mM NaCl, 10% glycerol

Purity: ≥75% estimated by SDS-PAGE

• Group-VIIA phospholipase A₂
• LDL-PLA(2)
• Lipoprotein PLA₂
• PAF-AH
• PLA₂G7
• gVIIA-PLA₂
• Lp-PLA₂
• Platelet-activating Factor Acetylhydrolase

Formulation: 50 mM of sodium phosphate, pH 7.2, with 100 mM sodium chloride and 20% glycerol

Purity: ≥90% estimated by SDS-PAGE

• Adipocyte FABP
• A-FABP
• ALBP
• aP2
• Fatty Acid Binding Protein 4
• Fatty Acid Binding Proetein (Adipocyte)

Formulation: 50 mM Tris-HCl, pH 8.0, containing 100 mM sodium chloride, 50 mM calcium chloride, and 20% glycerol

Purity: ≥90% estimated by SDS-PAGE

• gVPLA₂
• Phosphatidylcholine 2-acylhydrolase 5
• PLA₂G5
• Secretory Phospholipase A₂ (Group V)

Formulation: 50 mM HEPES, pH 7.4, with 100 mM sodium chloride, 5 mM MgCl₂, 0.1% CHAPS, and 25% glycerol

Purity: ≥90% estimated by SDS-PAGE

• MAGL
• MGL

Formulation: Each vial, when reconstituted to 0.5 ml with water, contains 1 mg of diphtheria toxin in 0.01 M Tris and 0.001 M Na2EDTA at pH 7.5

Purity: ≥90% (estimated by SDS-PAGE)